Operating Margin of Avalo Therapeutics, Inc. from 31 Dec 2016 to 31 Dec 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Avalo Therapeutics, Inc. quarterly and annual Operating Margin in % history and change rate from 31 Dec 2016 to 31 Dec 2024.
  • Avalo Therapeutics, Inc. Operating Margin for the quarter ending 31 Dec 2024 was -15536%, a 993% decline year-over-year.
  • Avalo Therapeutics, Inc. annual Operating Margin for 2017 was 50%.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)

Avalo Therapeutics, Inc. Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q4 2024 -15536% -14114% -993% 01 Oct 2024 31 Dec 2024
Q3 2024 -7675% -6407% -505% 01 Jul 2024 30 Sep 2024
Q2 2024 -6669% -6547% -5365% 01 Apr 2024 30 Jun 2024
Q1 2024 -3542% -3396% -2322% 01 Jan 2024 31 Mar 2024
Q4 2023 -1422% -1214% -585% 01 Oct 2023 31 Dec 2023
Q3 2023 -1269% -1001% -374% 01 Jul 2023 30 Sep 2023
Q2 2023 -122% +1655% +93% 01 Apr 2023 30 Jun 2023
Q1 2023 -146% +1041% +88% 01 Jan 2023 31 Mar 2023
Q4 2022 -207% +1314% +86% 01 Oct 2022 31 Dec 2022
Q3 2022 -268% +938% +78% 01 Jul 2022 30 Sep 2022
Q2 2022 -1777% -576% -48% 01 Apr 2022 30 Jun 2022
Q1 2022 -1187% +443% +27% 01 Jan 2022 31 Mar 2022
Q4 2021 -1522% -434% -40% 01 Oct 2021 31 Dec 2021
Q3 2021 -1206% -130% -12% 01 Jul 2021 30 Sep 2021
Q2 2021 -1202% -448% -59% 01 Apr 2021 30 Jun 2021
Q1 2021 -1630% -1016% -165% 01 Jan 2021 31 Mar 2021
Q4 2020 -1087% -848% -355% 01 Oct 2020 31 Dec 2020
Q3 2020 -1076% -9346% -113% 01 Jul 2020 30 Sep 2020
Q2 2020 -754% +1180% +61% 01 Apr 2020 30 Jun 2020
Q1 2020 -614% +101% +14% 01 Jan 2020 31 Mar 2020
Q4 2019 -239% +264% +53% 01 Oct 2019 31 Dec 2019
Q3 2019 8270% +8509% 01 Jul 2019 30 Sep 2019
Q2 2019 -1933% -1955% -8960% 01 Apr 2019 30 Jun 2019
Q1 2019 -715% -752% -2019% 01 Jan 2019 31 Mar 2019
Q4 2018 -503% -553% -1108% 01 Oct 2018 31 Dec 2018
Q3 2018 -239% 01 Jul 2018 30 Sep 2018
Q2 2018 22% 01 Apr 2018 30 Jun 2018
Q1 2018 37% 01 Jan 2018 31 Mar 2018
Q4 2017 50% 01 Oct 2017 31 Dec 2017

Avalo Therapeutics, Inc. Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2017 50% +1445% 01 Jan 2017 31 Dec 2017
2016 -1395% 01 Jan 2016 31 Dec 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.